ArticleJournal of nanobiotechnology2026
Flexible laser-induced graphene biosensor enables real-time, in vivo profiling of wound healing cytokine dynamics.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Laser-induced graphene (LIG) provides a scalable route to high-performance carbon nanomaterials, but its biomedical translation has been hindered by limited robustness, biocompatibility, and in vivo validation. Here, we report a flexible, elastomer-integrated LIG biosensor that enables continuous monitoring, label-free monitoring of inflammatory cytokines within living tissue. By systematically optimizing the laser processing parameters, we generated stable, low-resistance graphene networks that maintained electrical fidelity under repeated bending and adhesion stress. Antibody functionalization conferred molecular specificity, allowing picogram-per-milliliter detection of interleukin-6 (IL-6), CXCL12, and TGF-β1 with performance comparable to ELISA. In a chronic wound model, the biosensor resolved cytokine-specific temporal dynamics across inflammatory, proliferative, and remodeling phases, validated by conventional assays. This platform provides minimally invasive and longitudinal profiling of inflammatory signaling, establishing LIG biosensors as clinically translatable tools for precision monitoring in wound healing, neuroinflammation, and other inflammation-driven disorders. Such direct and mechanically stable interfacing with the wound microenvironment enables continuous in vivo cytokine profiling beyond conventional wearable or adhesive biosensing approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.